SlideShare une entreprise Scribd logo
1  sur  26
Télécharger pour lire hors ligne
BASIC CONCEPT
OF MEDICINE &
POISON
INFORMATION
SERVICES
Submitted By,
Ameena Kadar K A
First Sem M Pharm
Clinical Pharmacy Practice
Sanjo College of Pharmaceutical Studies
Submitted To,
Soumya Ma’am
Assistant Professor
Dept. of Pharmacy Practice
1
DRUG INFORMATION SERVICES
INTRODUCTION
 Providing drug information is a fundamental responsibility of all pharmacists.
 Drug information means providing clinically relevant information on any
aspect of drug use relating to individual patients, or general information on
how best to use drugs for populations.
 Pharmacists have a unique range of knowledge and skills which are required for
drug information practice. These include knowledge of pharmaceutics,
pharmacology, pharmacokinetics and pharmacotherapy. All of these are
required to optimize the use of drugs in the treatment and prevention of disease.
 Drug information can be challenging but also exciting. It requires much of the
knowledge that pharmacists acquire as students and allows them to apply these
skills to improve health outcomes.
 Providing a drug information service is a professional activity which carries the
same responsibilities as direct patient care. Information provided to support
policy decisions can affect many people (hospital, regional or national
populations) and poor-quality information can cause as much damage to public
health as inadequate quality control in pharmaceutical manufacturing.
 The term ‘Drug Information Service’ can be applied to any activity where
information about drug use is transferred, and includes patient-related
aspects of pharmaceutical care.
 A ‘Drug Information Centre’ is an area where pharmacists (or other health
professionals) specialize in providing information to health professionals or
the public.
2
 The term ‘medicines information’ can be used to avoid confusion with services
which are limited to problems relating to drugs of abuse.
 Drug information centres were first established in the USA in the early 1960s
and developed in parallel with clinical pharmacy services.
Drug information centres can limit their services to health professionals but
some also offer a service to the public, there are also centres which specialize in
information for the public.
DRUG INFORMATION RESOURCES
Information sources have traditionally been categorized as primary, secondary or
tertiary, according to the nature of the content and speed of publication. However,
the most important point is to distinguish primary sources (original reports) from
all other sources (reviews). Electronic formats, and ready access to updates, have
blurred the divisions previously applied to secondary and tertiary sources.
PRIMARY RESOURCES
 Primary literature describes unique experiences which change the world in
terms of available knowledge.
 Primary reports include the results of research at all levels (from molecular
science to controlled clinical trials) and also clinical experience in the form of
individual responses to drugs and small case series.
 Primary literature is published principally in scientific journals in the form
of research results, concise reports and letters to the editor.
 Adverse drug reaction reports are an example of primary literature and these
can be published in journals or contributed to pharmacovigilance centres.
3
 Primary literature can be seen as the building block on which medical science
(and therefore clinical practice) is based.
 It is essential to understand its nature and to be able to critically analyze its
content using the full text of reports.
 Primary literature provides a ‘first look’ at how clinical practice may evolve but
it must be constantly monitored and interpreted carefully.
Eg: Journal of Clinical and Hospital Pharmacy, Journal of Pharmaceutical
Sciences.
SECONDARY RESOURCES
 It consists of reviews of primary reports.
 Journals often publish a mixture of primary and secondary reports but there are
also journals which are devoted to reviews of previously published material.
 Reviews can be informal, often by a single author recognized as a specialist in
the field.
 These provide a personal perspective of the literature and can include comments
on how the author might apply the information in practice.
 This type of report is sometimes called a ‘narrative review’ and this term may
appear in the title to distinguish it from a more formal analysis, referred to as a
‘systematic review’
 In a systematic review, the authors (usually a team) use a rigorous (and defined)
method to search for all relevant information (including unpublished studies)
and select those studies which meet criteria for scientific quality.
 The selected studies are then analyzed and conclusions drawn.
 In many cases, the results of a number of studies are merged using a process
called ‘meta-analysis’, this process aims to create the equivalent of one large
study with greater statistical power than the separate studies.
4
 Secondary sources provide a condensed and refined view of primary data and
are often used in drug information practice to provide rapid responses to
clinical questions.
 However, published reviews may not include recent primary reports, and
narrative reviews may reflect the authors’ clinical perspective and limited
access to the relevant information.
 Eg: Index Medicus, MEDLINE, PubMed, Ovid, SEDBASE, Toxline, Cochrane
Database.
TERTIARY RESOURCES
 Tertiary resources are summaries of the primary and secondary published
literature.
 Printed textbooks are the main example and these are characterized by a slow
rate of revision compared to secondary sources.
 Although they are revised less frequently, these texts tend to be more
comprehensive and should undergo a more thorough review and editing process
than secondary sources.
 Many major textbooks are now published electronically as well as in print, so
sections can be updated progressively rather than waiting for a complete
revision at the time of printing (usually every 3–5 years).
 In drug information practice, a tertiary text will usually be consulted first
as a quick reference and, if necessary, secondary and primary sources are
then checked for a more complete response.
 Eg; Harrisons Principles of Internal Medicine, Martindale, Pharmacopoeias,
Merck index, Merck manual etc.
5
OTHER SOURCES OF DRUG INFORMATION
The internet has enhanced our access to information from reputable organizations.
National libraries offer reliable information and links to useful sites, including
openaccess journals. Many clinical guidelines and drug assessments are not
indexed in bibliographical databases but can be located on recognised sites or
using search engines which focus on reputable sources of information.
Examples of specific sites include:
 National Institute for Health and Clinical Excellence, UK (www.nice.org.uk)
 National Prescribing Centre, UK (www.npc.co.uk)
 National Prescribing Service, Australia (www.nps.org.au)
 Canadian Agency for Drugs and Technologies in Health (www.cadth.ca)
Search tools for clinical guidelines include:
 National Guideline Clearinghouse, USA (www.guidelines.gov)
 National Library for Health, UK (www.library.nhs.uk).
Product information is available for approved drugs in many countries including:
 DailyMed, USA (dailymed.nlm.nih. gov/dailymed)
 European Medicines Agency (www.emea.europa.eu)
 Medicines.org.uk, UK (www.medicines.org.uk).
Drug information about understands all available information resources, selecting
and using the most useful, and being able to retrieve and interpret that information
in a clinical or public health context.
6
FUNCTIONS OF DIC
1. Promoting rational drug evaluation and therapeutics
o It can evaluate the information on products available in the market and prepare
rationalised drug monographs that may overcome the imbalance between
commercially oriented and purely scientific sources of drug information.
o Drug product oriented stored at also includes data on product availability,
manufacturer, package strength, cost, OTC products, and identification of
foreign drug products.
2. Patient specific consultations
o Drug information specialist may actively disseminate information related to
patient care where he attends ward rounds or reviews a patient’s chart along
with physicians.
o Specialist may passively participate in patients care by responding to queries
received at the DIC.
3. Adverse reaction reporting:
o The drug information specialist plays an important role by following up such
patients filling and analysing the forms needed for detection and reporting
adverse reactions.
4. Drug interaction monitoring:
o Multiple drug therapies have resulted in growing incidence of drug-drug
interaction. The DIC services may evaluate reports on drug interactions and
suggest ways to detect interactions and to determine their clinical significance.
5. Drug interaction with diagnostic tests:
o Many diagnostic and pathological test results are found to be modified due to
concurrent drug administration. DIC service can provide manual or
7
computerised information on such interferences and saves the patients of under
surgical procedures and wrong diagnosis based on altered test result.
6. Drug utilisation review
o The pharmacist at the drug information centres can be actively involved in
conducting drug utilisation reviews to determine patterns of drug usage in the
hospital.
7. Pharmacy and therapeutics committee related function
o This is the most important non patients’ specific activity of the DIC to provide
specific drug reports for evaluations by the committee.
8. Investigational drug information
o The drug information specialist can participate in clinical investigations to
establish safety and efficacy of new drug. He can assist in preparation of
protocols, applications & literature reports & investigational drugs.
9. Publication of news letters
o DIC can publish newsletters, news bulletins or periodic reports; subject matter
in such publications includes all the topics of current interest to staff.
o E g : news products , drug reviews , new drug policies , specific diseases ,
comparative therapies.
10. Teaching and education activities
o Educational functions include developing continuing education programmes for
staff pharmacist, a resident doctor, intern nurses etc… DIC can organise
seminars, conference, workshops and guest lectures by eminent scientist.
11. Consumer awareness programmes & community pharmacy based activity
o The DIC can create awareness for safe drug usage.
o It can prepare attractive sheets for consumers for audio-visual aids such as
cassette tapes called media messages for counselling of ambulatory patients.
12. Literature retrieval services
o Drug literature is defined as any published paper on preparations with the
potential therapeutic or diagnostic activity.
o A DIC can be at the interference of this literatures and the user who seeks it.
o Having up to date information alone does not automatically ensure information
of high quality but the effective communication of this information to the
person who requested for it is also important.
8
 APPROACH TO ANSWERING DRUG INFORMATION QUERIES
The major steps involved are:
Step 1: Secure demographics of requester
Step 2: Obtain background information
Step 3: Determine and categorise the ultimate questions
Step 4: Develop search strategy and conduct search
Step 5: Perform evaluation, analysis and synthesis
Step 6: Formulate and provide response
Step 7: Conduct follow up & documentation.
Step 1: Secure demographics of requester
o The requesters name, position, training and anticipated knowledge are
important to determine the approval and final response to the question.
Step 2: Obtain background information
o The ability to obtain background information is essential for effectively using
the modified systematic approach.
o The background question should be specific for the nature of the request.
o When a question involves a patient, the patient’s age, weight and sex are
usually needed. On addition, the patients’ diagnosis, other comorbidities, and
hepatic & renal function are often important to assess.
o It is also advisable to find out if the requester has checked any resources
previously so as to avoid duplication of work.
Step 3: Determine & categorise the ultimate question
o The ultimate question may differ significantly from the if the requester posed a
general question.
9
o Adequate background information is needed to determine the ultimate question.
Thereafter the question should be categorised, as it will help in developing
search strategy.
Step 4: Develop search strategy and conduct search
o The information resources are selected based on the probability of containing
the desired information on data.
o If query is about any drug interactions, standard reference on drug interactions
is first line resources. However, if one of the drugs was a recently introduced
drug a Medline search would be more appropriate.
Step 5: Perform evaluation, analysis and synthesis
o The information retrieved must be reviewed for the response to be analysed and
synthesised with the consideration of the background information obtained
previously.
o Analysis and synthesis together assist in forming opinions, arriving at
judgements and ultimately drawing conclusions.
Step 6: Formulate & provide response
o This involves a series of steps that must be performed completely objectively
and in a logical sequence.
o The way in which answers are communicated plays a major role in determining
how drug information accepted by physicians.
o Conflicting viewpoints or considerations should be clear stated. Specific
recommendation must be scientifically sound & clearly justified.
10
o In the hospital setting the majority of questions will be answered verbally and
responses should be brief, concise and accurate and provided in a timely
manner.
Step 7: Conduct follow up & documentation
o Follow up is the process of verifying the appropriateness, correctness, and
completeness of a response after it has been given.
o When recommendations are made, follow up should always be done in a timely
manner. This follows pharmacist to know if the recommendations were
accepted and implemented.
o In a hospital setting this may involve visiting the ward and offering additional
advice & information.
o Documentation of DI query is essential for purpose of quality assurance, budget
allocation, promotion of the DI service & to minimise liability.
PREPARATION OF WRITTEN AND VERBAL RESPONSES:
Preparation of written response:
Goal:
Is to prepare a document that is clear, concise, complete and correct.
General rules:
 Organize the information before starting to write (what and how to write)
 Use proper spelling and grammar
 Preferably avoid passive voice throughout
11
 Avoid writing in the first person and second person wherever possible.
 Prepare a document in a presentable manner (neat)
 Keep things as simple and direct as possible
 Consider whether tables or graphs or figure would make the document
simpler
 Avoid using abbreviations or acronyms (or quote at first instance in
parentheses)
 If the document is long , use sub headings
 Present it in correct order as required
 Write in your own words
 At first make sure that all of the information is down on paper. Once that
occurs go back, revise, and perhaps reorganize the document.
Specific document sections:
It should contain
 Introduction
 Body
 Conclusion
Introduction: Should inform what the remainder of the document is to cover
Body: Should contain all the details of the document.
 Do not include unnecessary information (even if it is interesting)
12
 Do not stray from the subject
 Subdivide the document further in a logical order and as appropriate when
necessary.
 Always focus end point
Conclusion:
 Should be placed at the end of the document
 Avoid extrapolating beyond the information available
 Readers need something to bring their thoughts together at the end
Preparation of verbal response:
 Verbal communications are most frequently used in practice setting
 Need to use good verbal communication skills
 Deliver the information at an ideal place
 Deliver the content confidently
 Make analogous to the delivery to the delivery of a presentation or lecture
 Use appropriate language with good grammar
 Use correct pronunciation all of terms of the document
 Listen carefully when clarification is sought
 Clarify all doubts confidently
 Must be prepared for additional questions
 Show evidence where necessary or appropriate.
13
14
15
POISON INFORMATION SERVICES
The number of chemicals, poisonous household products and medicines on the
Indian market is increasing day by day, which consequently increases the risk of
misuse of these products and leads to greater incidence of intentional and
unintentional poisoning. The impact of poison information services on the quality
of healthcare is very significant, and hence there is an increased need for poison
information services to prevent and manage the morbidity and mortality caused by
poisoning. Such services are designed to provide immediate, round-the-clock
toxicity assessment and treatment recommendations for the effective management
of poisoning cases.
Poison information (PI) is a specialized area of drug information which
includes information about the toxic effects of chemicals and pesticides,
hazardous material spills, household products, overdose of therapeutic
medicines, plants including mushrooms, animal toxins from the bites of
snakes, spiders and other venomous creatures, and stings.
A poison information service deals with the risk assessment, diagnosis,
management and prevention of exposure to any poison, in patients of any age
irrespective of type (intentional or accidental) and route of exposure.
The goal of poison information services is to reduce the morbidity and
mortality caused by poisoning and improves the patients’ health-related
quality of life.
These services are mainly provided to the general public as well as to healthcare
professionals. Specialist pharmacists with knowledge of clinical toxicology and
with the skills required for provision of drug and poison information can contribute
16
to the management of poisoning cases. Pharmacists can acquire the required
knowledge and skills through appropriate training in the area of poison information
which enables them to evaluate poisoning cases with in-depth understanding, and
thereby provide valuable information.
 Poison information services are provided by a specialized center known as a
poison information center (PIC) or poison control center (PCC).
 It provides immediate information on poisoning management through
well trained poison information specialists.
 A PIC functions 24 hours a day, round the year with the objective of
continually improving health outcomes by providing a timely, safe information
service appropriate to the needs of the enquirer related to poisoning, suspected
poisoning and prevention of poisoning.
 It also aims to prevent unnecessary visits to doctors and hospitals and to ensure
that patients who are poisoned receive the most effective treatment promptly.
 The size of the PIC may vary depending on call volumes and should ideally be
located adjacent to the emergency department.
 A PIC may operate locally, providing services to populations of a specific
geographical location, or may extend its service to the regional/national level.
Role of the Poison Information Centre
 To minimize poisoning deaths due to accidental or intentional poisoning or
overdose among the general public.
 Providing the general public and healthcare professionals with information on
poisoning prevention and management (identification/ assessment and
management) by providing rapid access to poisoning information.
17
 Educational programs for healthcare professionals of the hospital where the PIC
is located, and outreach programs at smaller hospitals may also be developed.
 The identification of the poisoning substance, first aid measures and the
treatment and prevention of poisoning cases.
 PIC staff can also assist with rationalization of antidote stocks.
 Healthcare professionals have access to up-to-date and relevant information
about poisoning management.
Functions of a poison information center
 Patient management
 Toxicological analytical services
 Toxic vigilance
 Education and training of healthcare professionals and public
 Prevention of poisoning
 Research in poisoning
 Development of therapeutic guidelines/protocols for poison management.
Organization
The organization pattern of a PIC should be based on the anticipated ‘ideal human
exposure call volume’ (average number of queries that the poison information
center receives regarding the management of poisoning cases in humans). The
majority of PICs are connected with hospitals and to some extent to universities
and with the public health service of the country at national or regional level.
Networking with all other existing PICs at a regional, state or national level in a
systematic way is essential not only for maintaining uniformity of services but also
to ensure better utilization of available resources. This also allows the development
18
of a national database on poisoning and the formulation of expert management
advice.
Personnel
An adequate number of staff is essential for effective and round the-clock
functioning of the Centre. The PIC is usually staffed by a physician (medical
director), a pharmacist (technical director), an administrator, at least one
clinical toxicologist and a poison information specialist with the required
secretarial assistance. Personnel working in PICs should have unique qualifications
and distinct responsibilities.
The responsibility of medical and technical directors is to promote research, raise
funds, ensure quality service and undertake further development of the information
service.
The poison information specialists should be trained properly to carry out the basic
functions of the Centre. The responsibilities of the poison information specialist
include:
 Provide poison information
 Prepare standard protocols
 Maintain an accurate record of all queries
 Participate in continuing education
 Update and maintain information resources
 Carry out research activities.
Facilities
Location: A feasible location for the PIC is within a hospital or an area closely
associated with a hospital providing emergency and intensive care services.
19
Ideally, the PIC should be co-located with a hospital clinical toxicology service
which is concerned with the identification, treatment and prevention of the harmful
effects of chemicals, including natural substances, on humans.
This type of setup will provide ready access to a network of medical disciplines
that will support and enhance the work of the Centre.
Other locations include a medical library, medical university, pharmacy
department and medical or pharmacy college. Regardless of the location, it is wise
to have a liaison with a hospital/ university medical library.
Space: The PIC should be placed in a spacious facility to accommodate the
service’s staff and needs. A work area of 200 square feet per workstation is
recommended, with a separate office for the medical director and manager/
supervisor. The working area should have adequate lighting and ventilation.
Equipment: The PIC should be well equipped with the necessary basic facilities,
including furniture, to allow it to function effectively. Communication equipment
is vital for the Centre. As most communication with the enquirer is over the phone,
at least two telephones with sufficient incoming lines with toll-free numbers should
be reserved to receive the queries. It is essential to have other fast and reliable
communication options such as fax and e-mail. It is also important to be equipped
adequately with computers, printers, a photocopying machine and uninterrupted
power supply (UPS). Book shelves and filing cabinets for storage of case records
and documentation files for systematic storage and easy retrieval of data are also
essential. A lockable cabinet should also be available to store confidential data. For
toxicological screening purposes, either the required facilities need to be created or
the center can liaise with a well-equipped laboratory which carries out
toxicological analysis.
20
Information resources: Information pertaining to the management of poisoning
cases is available from a wide range of information sources including primary,
secondary and tertiary resources and the internet
Tertiary Resources:
 Medical and general toxicology: Murray L, Dary F, Little M and Cadogan M
(eds). 2007. Toxicology Handbook. Churchill Livingstone, Elsevier: Australia.
 Goldfrank LR, Flomenjbaum NE and Lewin NA (eds).2006. Goldfrank’s
Toxicologic Emergencies, 6th ed. Appleton and Lange: Norwalk.
Secondary resources:
 POISINDEX
 WikiTox / http://curriculum.toxicology.wikispaces.net/
 Toxbase
 MEDLINE
 Toxicology abstracts
 Toxline
 Excerpta medica
 Index medicus.
Primary resources
 Human and experimental toxicology. Published by Macmillan, Basingstoke,
England.
 On-line journal scanning services, for example, AMEDEO, Current Awareness
in Clinical Toxicology
 Clinical toxicology. Published by Informa Healthcare.
 Neurotoxicology. Published by Raven Press, New York, USA
21
Legal and ethical prerequisites: It is recommended that the PIC be officially
reIntoxcognised either by government authorities or the WHO. To carry out the
functions effectively, the Centre should have independent status, stability and
neutrality. The Centre should maintain confidentiality of the data it handles.
Usually the Centre is required to provide the information free of cost to enquirers.
But, occasionally, the Centre may charge for the services being offered for its own
viability. In such instances, it should be on a ‘no loss–no profit’ basis.
Policies and procedures: For the effective functioning of the Centre, it should
have well-defined policies and procedures. The policies and procedures may vary
from one Centre to another depending on the scope of service, financial support
and the Centre’s requirements. The PIC should develop policies for personnel,
methods of operation, documentation of services and quality assurance programs,
staff training, confidentiality, and ethical and legal aspects. Policies pertaining to
personnel should indicate the mode of recruitment of personnel, qualifications and
training required if any, and the position of staff with distinct responsibilities. The
method of operation should detail the handling of poisoning cases starting from
receipt of the query until final documentation.
Training of staff: Adequate training to site personnel is essential especially for
newly recruited and inexperienced staff. The PIC should provide either internal or
external training to the staff in the various areas of poison information. The PIC
should develop and implement a needs-based staff training manual. This would
assist in training new and inexperienced staff in various areas and ensure that
uniformity in training is maintained. Training components may include updating of
knowledge in clinical toxicology, communication skills, handling of databases,
retrieval of information, interpretation and analytical skills, and handling of
equipment such as computers, telephones and other instruments.
22
Systematic Approach in Handling Poison Information Queries
Step 1: Obtain the Requester’s Demographics
Receive and accept the query related to the service either over the phone or in
person. Establish the identity of the enquirer by gathering contact details. Also
obtain all required information from the requester that will allow you to reply to
the query. If the enquirer is a healthcare professional, the position and anticipated
knowledge of the enquirer should be determined. If it takes time to obtain
information, ask the enquirer to call back or note their contact number. Queries
relating to potentially serious poisoning cases need to be answered immediately,
and for a query with minimal toxicity an appropriate deadline for a response should
be established.
Step 2: Collect Background Information
It is important to collect all the required background information to provide
appropriate information. Obtaining relevant information often requires targeted
questioning, and additional care is required to accurately identify the poisoning
substance. However, all critical information should be obtained in a short time to
maximize the patient outcome as otherwise it may be counter-productive.
Step 3: Assess the Patient’s Condition
Appropriate background information about the patient’s condition allows for better
understanding of the actual query to be answered. Firstly, the urgency of the
situation should be assessed in terms of whether it is an emergency, serious, not
serious or no problem. Assess the likelihood of toxicity associated with the
exposed toxins based on the nature of the substance, type of exposure and quantity
consumed. Assessment of signs and symptoms of toxicity and analytical testing of
23
the compound may greatly aid in determining appropriate patient management and
whether first aid, observation, medical treatment, home treatment or no treatment
is appropriate.
Step 4: Develop and Conduct a Search Strategy
Select and prioritizes the information resources based on the probability of locating
the desired information. It is ideal to locate the information based on the probable
efficiency of information sources in the literature hierarchy. Although in many
instances the information can be provided with the use of tertiary resources, it is
worthwhile to consider other information sources, as appropriate.
Step 5: Evaluate and Provide Information
The retrieved information should be thoroughly and critically evaluated.
Comprehensive information needs to be provided to ensure the recommended line
of management is based on all of the current evidence available. The response
should be generated only after critically evaluating all the information available.
However, consistency of information among the resources used should be ensured.
Interpretation of the information available in various resources should be patient
specific and made considering all relevant factors. In case of lack of information or
conflict of information in the available sources, a decision may be taken based on
professional knowledge and previous experience. Information may be provided
verbally/written/printed form/through fax or e mail, as appropriate. However,
timely or immediate delivery of the response is critical. If more time is required to
evaluate and formulate the response, minimum vital information is to be provided
at the earliest possible time.
24
Step 6: Conduct Follow-up and Document
Follow-up of the case is vital to assess the patient outcome and also to ascertain
whether provision of any additional information is useful in the management of the
poisoning. A personal visit may be more useful and is possible only when the
victim is admitted to a hospital where the poison information Centre is co-located.
In other cases, follow- up can be made through other modes including telephone
enquiry and e-mail. Documenting the details of enquirer, query and response.
Step 7: Maintain Confidentiality
All issues relating to the query are to be kept confidential by the Centre for socio-
legal reasons. The details of the enquirer should not be disclosed to anyone,
including family members and healthcare professionals, without the consent of the
enquirer.
COMPARISON OF PIC AND DRUG INFORMATION CENTRE
25
Conclusion
Skilled pharmacists can play an important role as poison information specialists.
This role is most effective when the PIC is co- located with a clinical toxicology
service within a hospital treating poisoning cases. Experienced pharmacists may
also serve as advisors to analytical toxicology laboratories, as expert witnesses in
legal proceedings, and may also work in the safety offices of the pharmaceutical
industry.
There is a need for a centralized database and expert advice on toxicological cases
to assist physicians, and to educate the public in the prevention and the overall
management of poisoning in India.
REFERENCES:
A Textbook of Clinical Pharmacy Practice: Essential Concepts and Skills. By G Parthasarathi,
Karin Nyfort-Hansen, Milap C Nahata. 2nd
Edition, Page No. 534-584.
THANK YOU!

Contenu connexe

Tendances

Developing therapeutic guidelines
Developing therapeutic guidelines  Developing therapeutic guidelines
Developing therapeutic guidelines Irene Vadakkan
 
Drug information and poison information
Drug information and poison informationDrug information and poison information
Drug information and poison informationTHUSHARA MOHAN
 
Introduction to clinical pharmacy
Introduction to clinical pharmacyIntroduction to clinical pharmacy
Introduction to clinical pharmacyDr. Ramesh Bhandari
 
Critical evaluation of biomedical literature - clinical pharmacy
Critical evaluation of biomedical literature - clinical pharmacyCritical evaluation of biomedical literature - clinical pharmacy
Critical evaluation of biomedical literature - clinical pharmacyShaistaSumayya
 
Establishing a drug information center
Establishing a drug information centerEstablishing a drug information center
Establishing a drug information centerkatta amulya
 
Patient data analysis
Patient data analysisPatient data analysis
Patient data analysisRafi Bhat
 
7 continuing professional development programs
7 continuing professional development programs7 continuing professional development programs
7 continuing professional development programsChanukya Vanam . Dr
 
Patients medication history interview
Patients medication history interviewPatients medication history interview
Patients medication history interviewSubhash Yende
 
Adverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reportingAdverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reportingTHUSHARA MOHAN
 
clinical pharmacy
clinical pharmacyclinical pharmacy
clinical pharmacySohan Patel
 
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...Community pharmacy-Definition ,scope and Roles and responsibilities of commun...
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...MerrinJoseph1
 
Rational use of otc medication
Rational use of otc medicationRational use of otc medication
Rational use of otc medicationRafi Bhat
 
14ab1t0030 hospital formulary
14ab1t0030   hospital formulary14ab1t0030   hospital formulary
14ab1t0030 hospital formularyRamesh Ganpisetti
 
Pharmacovigilance and role of pharmacist
Pharmacovigilance and role of pharmacistPharmacovigilance and role of pharmacist
Pharmacovigilance and role of pharmacistDr. Ramesh Bhandari
 
Ward round participation
Ward round participationWard round participation
Ward round participationSarah Pulackal
 
Hospital and its organisation, BUDGET AND pHARMACY AND tHERAPEUTIC COMMITTEE
Hospital and its organisation, BUDGET AND pHARMACY AND tHERAPEUTIC COMMITTEEHospital and its organisation, BUDGET AND pHARMACY AND tHERAPEUTIC COMMITTEE
Hospital and its organisation, BUDGET AND pHARMACY AND tHERAPEUTIC COMMITTEESanju Kaladharan
 

Tendances (20)

Developing therapeutic guidelines
Developing therapeutic guidelines  Developing therapeutic guidelines
Developing therapeutic guidelines
 
14ab1t0009 newsletter
14ab1t0009    newsletter14ab1t0009    newsletter
14ab1t0009 newsletter
 
Drug information and poison information
Drug information and poison informationDrug information and poison information
Drug information and poison information
 
Introduction to clinical pharmacy
Introduction to clinical pharmacyIntroduction to clinical pharmacy
Introduction to clinical pharmacy
 
Critical evaluation of biomedical literature - clinical pharmacy
Critical evaluation of biomedical literature - clinical pharmacyCritical evaluation of biomedical literature - clinical pharmacy
Critical evaluation of biomedical literature - clinical pharmacy
 
Establishing a drug information center
Establishing a drug information centerEstablishing a drug information center
Establishing a drug information center
 
Patient data analysis
Patient data analysisPatient data analysis
Patient data analysis
 
Drug utilization evaluation
Drug utilization evaluationDrug utilization evaluation
Drug utilization evaluation
 
7 continuing professional development programs
7 continuing professional development programs7 continuing professional development programs
7 continuing professional development programs
 
Patients medication history interview
Patients medication history interviewPatients medication history interview
Patients medication history interview
 
Drug information services
Drug information servicesDrug information services
Drug information services
 
Adverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reportingAdverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reporting
 
Hospital formulary
Hospital formularyHospital formulary
Hospital formulary
 
clinical pharmacy
clinical pharmacyclinical pharmacy
clinical pharmacy
 
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...Community pharmacy-Definition ,scope and Roles and responsibilities of commun...
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...
 
Rational use of otc medication
Rational use of otc medicationRational use of otc medication
Rational use of otc medication
 
14ab1t0030 hospital formulary
14ab1t0030   hospital formulary14ab1t0030   hospital formulary
14ab1t0030 hospital formulary
 
Pharmacovigilance and role of pharmacist
Pharmacovigilance and role of pharmacistPharmacovigilance and role of pharmacist
Pharmacovigilance and role of pharmacist
 
Ward round participation
Ward round participationWard round participation
Ward round participation
 
Hospital and its organisation, BUDGET AND pHARMACY AND tHERAPEUTIC COMMITTEE
Hospital and its organisation, BUDGET AND pHARMACY AND tHERAPEUTIC COMMITTEEHospital and its organisation, BUDGET AND pHARMACY AND tHERAPEUTIC COMMITTEE
Hospital and its organisation, BUDGET AND pHARMACY AND tHERAPEUTIC COMMITTEE
 

Similaire à poison and drug info.pdf

3. application of pharmacoinformatics
3. application of pharmacoinformatics3. application of pharmacoinformatics
3. application of pharmacoinformaticsaldebaran4
 
3. application of pharmacoinformatics
3. application of pharmacoinformatics3. application of pharmacoinformatics
3. application of pharmacoinformaticsaldebaran4
 
Hospital & Clinical Pharmacy.pdf
Hospital & Clinical Pharmacy.pdfHospital & Clinical Pharmacy.pdf
Hospital & Clinical Pharmacy.pdfHemanthiJetti
 
Drug information system.pptx
Drug information system.pptxDrug information system.pptx
Drug information system.pptxGopalpokhrel8
 
DIC & PIC .pptx
DIC & PIC .pptxDIC & PIC .pptx
DIC & PIC .pptxAjithJs2
 
Drug Information Centre
Drug Information CentreDrug Information Centre
Drug Information Centrevarshawadnere
 
critical evaluation of di literature.pptx
critical evaluation of di literature.pptxcritical evaluation of di literature.pptx
critical evaluation of di literature.pptxDrpradeepthi
 
systematic approach in answering Drug queries.pptx
systematic approach in answering Drug queries.pptxsystematic approach in answering Drug queries.pptx
systematic approach in answering Drug queries.pptxDrpradeepthi
 
Clinical literature evaluation
Clinical literature evaluationClinical literature evaluation
Clinical literature evaluationAhlam Sundus
 
New microsoft office power point presentation
New microsoft office power point presentationNew microsoft office power point presentation
New microsoft office power point presentationEmani Aparna
 
Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology ABUBAKRANSARI2
 
Webinar pv use case 23 march2016
Webinar pv use case 23 march2016Webinar pv use case 23 march2016
Webinar pv use case 23 march2016Ann-Marie Roche
 

Similaire à poison and drug info.pdf (20)

Drug information Services.pptx
Drug information Services.pptxDrug information Services.pptx
Drug information Services.pptx
 
3. application of pharmacoinformatics
3. application of pharmacoinformatics3. application of pharmacoinformatics
3. application of pharmacoinformatics
 
3. application of pharmacoinformatics
3. application of pharmacoinformatics3. application of pharmacoinformatics
3. application of pharmacoinformatics
 
Hospital & Clinical Pharmacy.pdf
Hospital & Clinical Pharmacy.pdfHospital & Clinical Pharmacy.pdf
Hospital & Clinical Pharmacy.pdf
 
DINDI.SANDHYA RANI
DINDI.SANDHYA RANIDINDI.SANDHYA RANI
DINDI.SANDHYA RANI
 
Drug information system.pptx
Drug information system.pptxDrug information system.pptx
Drug information system.pptx
 
DIC & PIC .pptx
DIC & PIC .pptxDIC & PIC .pptx
DIC & PIC .pptx
 
Drug Information Centre
Drug Information CentreDrug Information Centre
Drug Information Centre
 
critical evaluation of di literature.pptx
critical evaluation of di literature.pptxcritical evaluation of di literature.pptx
critical evaluation of di literature.pptx
 
systematic approach in answering Drug queries.pptx
systematic approach in answering Drug queries.pptxsystematic approach in answering Drug queries.pptx
systematic approach in answering Drug queries.pptx
 
Drug information center (dic)
Drug information center (dic)Drug information center (dic)
Drug information center (dic)
 
Drug Information.
Drug Information.Drug Information.
Drug Information.
 
Drug information services by BNP.pdf
Drug information services by BNP.pdfDrug information services by BNP.pdf
Drug information services by BNP.pdf
 
EBM ppt by ANN
EBM ppt by ANNEBM ppt by ANN
EBM ppt by ANN
 
HARSHINI SAIDU
HARSHINI SAIDUHARSHINI SAIDU
HARSHINI SAIDU
 
Clinical literature evaluation
Clinical literature evaluationClinical literature evaluation
Clinical literature evaluation
 
New microsoft office power point presentation
New microsoft office power point presentationNew microsoft office power point presentation
New microsoft office power point presentation
 
Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology
 
Webinar pv use case 23 march2016
Webinar pv use case 23 march2016Webinar pv use case 23 march2016
Webinar pv use case 23 march2016
 
Drug information resources
Drug  information resourcesDrug  information resources
Drug information resources
 

Plus de Ameena Kadar

APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH.pdf
APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH.pdfAPPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH.pdf
APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH.pdfAmeena Kadar
 
REVIEW OF LITERATURE AND SOURCES OF INFORMATION
REVIEW OF LITERATURE AND SOURCES OF INFORMATIONREVIEW OF LITERATURE AND SOURCES OF INFORMATION
REVIEW OF LITERATURE AND SOURCES OF INFORMATIONAmeena Kadar
 
INTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptxINTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptxAmeena Kadar
 
GENETIC POLYMORPHISM IN DRUG METABOLISM.pptx
GENETIC POLYMORPHISM IN DRUG METABOLISM.pptxGENETIC POLYMORPHISM IN DRUG METABOLISM.pptx
GENETIC POLYMORPHISM IN DRUG METABOLISM.pptxAmeena Kadar
 
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptx
ROLE OF INDUSTRY IN QUM  IN MEDICINE DEVELOPMENT 1.pptxROLE OF INDUSTRY IN QUM  IN MEDICINE DEVELOPMENT 1.pptx
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptxAmeena Kadar
 
REGULATION OF COMPLEMENTARY MEDICINES.pptx
REGULATION OF COMPLEMENTARY MEDICINES.pptxREGULATION OF COMPLEMENTARY MEDICINES.pptx
REGULATION OF COMPLEMENTARY MEDICINES.pptxAmeena Kadar
 
SCHIZOPHRENIA.pptx
SCHIZOPHRENIA.pptxSCHIZOPHRENIA.pptx
SCHIZOPHRENIA.pptxAmeena Kadar
 
DRUG USE MEASURES.pptx
DRUG USE MEASURES.pptxDRUG USE MEASURES.pptx
DRUG USE MEASURES.pptxAmeena Kadar
 
COMMUNICATION IN QUM.pptx
COMMUNICATION IN QUM.pptxCOMMUNICATION IN QUM.pptx
COMMUNICATION IN QUM.pptxAmeena Kadar
 
PARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptxPARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptxAmeena Kadar
 
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxINTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxAmeena Kadar
 
BUILDING BLOCKS & evaluation process in qum.pptx
BUILDING BLOCKS  & evaluation process in qum.pptxBUILDING BLOCKS  & evaluation process in qum.pptx
BUILDING BLOCKS & evaluation process in qum.pptxAmeena Kadar
 
ALZHEIMER DISEASE.pdf
ALZHEIMER DISEASE.pdfALZHEIMER DISEASE.pdf
ALZHEIMER DISEASE.pdfAmeena Kadar
 
RHEUMATOID ARTHRITIS.pptx
RHEUMATOID ARTHRITIS.pptxRHEUMATOID ARTHRITIS.pptx
RHEUMATOID ARTHRITIS.pptxAmeena Kadar
 
Responding to minor ailments - headache, food and drug allergy.pptx
Responding to minor ailments - headache, food and drug allergy.pptxResponding to minor ailments - headache, food and drug allergy.pptx
Responding to minor ailments - headache, food and drug allergy.pptxAmeena Kadar
 
Investigational Product.
Investigational Product.Investigational Product.
Investigational Product.Ameena Kadar
 
ADR MONITORING IN COMMUNITY PHARMACY.pdf
ADR MONITORING IN COMMUNITY PHARMACY.pdfADR MONITORING IN COMMUNITY PHARMACY.pdf
ADR MONITORING IN COMMUNITY PHARMACY.pdfAmeena Kadar
 

Plus de Ameena Kadar (20)

APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH.pdf
APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH.pdfAPPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH.pdf
APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH.pdf
 
REVIEW OF LITERATURE AND SOURCES OF INFORMATION
REVIEW OF LITERATURE AND SOURCES OF INFORMATIONREVIEW OF LITERATURE AND SOURCES OF INFORMATION
REVIEW OF LITERATURE AND SOURCES OF INFORMATION
 
INTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptxINTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptx
 
GENETIC POLYMORPHISM IN DRUG METABOLISM.pptx
GENETIC POLYMORPHISM IN DRUG METABOLISM.pptxGENETIC POLYMORPHISM IN DRUG METABOLISM.pptx
GENETIC POLYMORPHISM IN DRUG METABOLISM.pptx
 
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptx
ROLE OF INDUSTRY IN QUM  IN MEDICINE DEVELOPMENT 1.pptxROLE OF INDUSTRY IN QUM  IN MEDICINE DEVELOPMENT 1.pptx
ROLE OF INDUSTRY IN QUM IN MEDICINE DEVELOPMENT 1.pptx
 
Pain pathways.pdf
Pain pathways.pdfPain pathways.pdf
Pain pathways.pdf
 
REGULATION OF COMPLEMENTARY MEDICINES.pptx
REGULATION OF COMPLEMENTARY MEDICINES.pptxREGULATION OF COMPLEMENTARY MEDICINES.pptx
REGULATION OF COMPLEMENTARY MEDICINES.pptx
 
SCHIZOPHRENIA.pptx
SCHIZOPHRENIA.pptxSCHIZOPHRENIA.pptx
SCHIZOPHRENIA.pptx
 
DRUG USE MEASURES.pptx
DRUG USE MEASURES.pptxDRUG USE MEASURES.pptx
DRUG USE MEASURES.pptx
 
COMMUNICATION IN QUM.pptx
COMMUNICATION IN QUM.pptxCOMMUNICATION IN QUM.pptx
COMMUNICATION IN QUM.pptx
 
PARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptxPARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptx
 
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxINTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
 
BUILDING BLOCKS & evaluation process in qum.pptx
BUILDING BLOCKS  & evaluation process in qum.pptxBUILDING BLOCKS  & evaluation process in qum.pptx
BUILDING BLOCKS & evaluation process in qum.pptx
 
ALZHEIMER DISEASE.pdf
ALZHEIMER DISEASE.pdfALZHEIMER DISEASE.pdf
ALZHEIMER DISEASE.pdf
 
RHEUMATOID ARTHRITIS.pptx
RHEUMATOID ARTHRITIS.pptxRHEUMATOID ARTHRITIS.pptx
RHEUMATOID ARTHRITIS.pptx
 
Responding to minor ailments - headache, food and drug allergy.pptx
Responding to minor ailments - headache, food and drug allergy.pptxResponding to minor ailments - headache, food and drug allergy.pptx
Responding to minor ailments - headache, food and drug allergy.pptx
 
Anemia.pptx
Anemia.pptxAnemia.pptx
Anemia.pptx
 
DIARRHEA.pdf
DIARRHEA.pdfDIARRHEA.pdf
DIARRHEA.pdf
 
Investigational Product.
Investigational Product.Investigational Product.
Investigational Product.
 
ADR MONITORING IN COMMUNITY PHARMACY.pdf
ADR MONITORING IN COMMUNITY PHARMACY.pdfADR MONITORING IN COMMUNITY PHARMACY.pdf
ADR MONITORING IN COMMUNITY PHARMACY.pdf
 

Dernier

The Events of Cardiac Cycle - Wigger's Diagram
The Events of Cardiac Cycle - Wigger's DiagramThe Events of Cardiac Cycle - Wigger's Diagram
The Events of Cardiac Cycle - Wigger's DiagramMedicoseAcademics
 
Call Now ☎ 8868886958 || Call Girls in Chandigarh Escort Service Chandigarh
Call Now ☎ 8868886958 || Call Girls in Chandigarh Escort Service ChandigarhCall Now ☎ 8868886958 || Call Girls in Chandigarh Escort Service Chandigarh
Call Now ☎ 8868886958 || Call Girls in Chandigarh Escort Service ChandigarhSheetaleventcompany
 
💚Chandigarh Call Girls Service 💯Jiya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Jiya 📲🔝8868886958🔝Call Girls In Chandigarh No...💚Chandigarh Call Girls Service 💯Jiya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Jiya 📲🔝8868886958🔝Call Girls In Chandigarh No...Sheetaleventcompany
 
Independent Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bang...
Independent Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bang...Independent Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bang...
Independent Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bang...Sheetaleventcompany
 
❤️Call Girl In Chandigarh☎️9814379184☎️ Call Girl service in Chandigarh☎️ Cha...
❤️Call Girl In Chandigarh☎️9814379184☎️ Call Girl service in Chandigarh☎️ Cha...❤️Call Girl In Chandigarh☎️9814379184☎️ Call Girl service in Chandigarh☎️ Cha...
❤️Call Girl In Chandigarh☎️9814379184☎️ Call Girl service in Chandigarh☎️ Cha...Sheetaleventcompany
 
Indore Call Girl Service 📞9235973566📞Just Call Inaaya📲 Call Girls In Indore N...
Indore Call Girl Service 📞9235973566📞Just Call Inaaya📲 Call Girls In Indore N...Indore Call Girl Service 📞9235973566📞Just Call Inaaya📲 Call Girls In Indore N...
Indore Call Girl Service 📞9235973566📞Just Call Inaaya📲 Call Girls In Indore N...Sheetaleventcompany
 
Low Rate Call Girls Pune {9142599079} ❤️VVIP NISHA Call Girls in Pune Maharas...
Low Rate Call Girls Pune {9142599079} ❤️VVIP NISHA Call Girls in Pune Maharas...Low Rate Call Girls Pune {9142599079} ❤️VVIP NISHA Call Girls in Pune Maharas...
Low Rate Call Girls Pune {9142599079} ❤️VVIP NISHA Call Girls in Pune Maharas...Sheetaleventcompany
 
2024 PCP #IMPerative Updates in Rheumatology
2024 PCP #IMPerative Updates in Rheumatology2024 PCP #IMPerative Updates in Rheumatology
2024 PCP #IMPerative Updates in RheumatologySidney Erwin Manahan
 
❤️Amritsar Call Girls Service☎️98151-129OO☎️ Call Girl service in Amritsar☎️ ...
❤️Amritsar Call Girls Service☎️98151-129OO☎️ Call Girl service in Amritsar☎️ ...❤️Amritsar Call Girls Service☎️98151-129OO☎️ Call Girl service in Amritsar☎️ ...
❤️Amritsar Call Girls Service☎️98151-129OO☎️ Call Girl service in Amritsar☎️ ...shallyentertainment1
 
Ulhasnagar Call girl escort *88638//40496* Call me monika call girls 24*
Ulhasnagar Call girl escort *88638//40496* Call me monika call girls 24*Ulhasnagar Call girl escort *88638//40496* Call me monika call girls 24*
Ulhasnagar Call girl escort *88638//40496* Call me monika call girls 24*Mumbai Call girl
 
💸Cash Payment No Advance Call Girls Bhopal 🧿 9332606886 🧿 High Class Call Gir...
💸Cash Payment No Advance Call Girls Bhopal 🧿 9332606886 🧿 High Class Call Gir...💸Cash Payment No Advance Call Girls Bhopal 🧿 9332606886 🧿 High Class Call Gir...
💸Cash Payment No Advance Call Girls Bhopal 🧿 9332606886 🧿 High Class Call Gir...India Call Girls
 
Call Girls Service Amritsar Just Call 9352988975 Top Class Call Girl Service ...
Call Girls Service Amritsar Just Call 9352988975 Top Class Call Girl Service ...Call Girls Service Amritsar Just Call 9352988975 Top Class Call Girl Service ...
Call Girls Service Amritsar Just Call 9352988975 Top Class Call Girl Service ...Escorts In Kolkata
 
Premium Call Girls Bangalore {9179660964} ❤️VVIP POOJA Call Girls in Bangalor...
Premium Call Girls Bangalore {9179660964} ❤️VVIP POOJA Call Girls in Bangalor...Premium Call Girls Bangalore {9179660964} ❤️VVIP POOJA Call Girls in Bangalor...
Premium Call Girls Bangalore {9179660964} ❤️VVIP POOJA Call Girls in Bangalor...Sheetaleventcompany
 
Top 20 Famous Indian Female Pornstars Name List 2024
Top 20 Famous Indian Female Pornstars Name List 2024Top 20 Famous Indian Female Pornstars Name List 2024
Top 20 Famous Indian Female Pornstars Name List 2024Sheetaleventcompany
 
Call Girl Service In Mumbai ❤️🍑 9xx000xx09 👄🫦Independent Escort Service Mumba...
Call Girl Service In Mumbai ❤️🍑 9xx000xx09 👄🫦Independent Escort Service Mumba...Call Girl Service In Mumbai ❤️🍑 9xx000xx09 👄🫦Independent Escort Service Mumba...
Call Girl Service In Mumbai ❤️🍑 9xx000xx09 👄🫦Independent Escort Service Mumba...Sheetaleventcompany
 
❤️Zirakpur Escorts☎️7837612180☎️ Call Girl service in Zirakpur☎️ Zirakpur Cal...
❤️Zirakpur Escorts☎️7837612180☎️ Call Girl service in Zirakpur☎️ Zirakpur Cal...❤️Zirakpur Escorts☎️7837612180☎️ Call Girl service in Zirakpur☎️ Zirakpur Cal...
❤️Zirakpur Escorts☎️7837612180☎️ Call Girl service in Zirakpur☎️ Zirakpur Cal...Sheetaleventcompany
 
💞 Safe And Secure Call Girls Prayagraj 🧿 9332606886 🧿 High Class Call Girl Se...
💞 Safe And Secure Call Girls Prayagraj 🧿 9332606886 🧿 High Class Call Girl Se...💞 Safe And Secure Call Girls Prayagraj 🧿 9332606886 🧿 High Class Call Girl Se...
💞 Safe And Secure Call Girls Prayagraj 🧿 9332606886 🧿 High Class Call Girl Se...India Call Girls
 
💸Cash Payment No Advance Call Girls Surat 🧿 9332606886 🧿 High Class Call Girl...
💸Cash Payment No Advance Call Girls Surat 🧿 9332606886 🧿 High Class Call Girl...💸Cash Payment No Advance Call Girls Surat 🧿 9332606886 🧿 High Class Call Girl...
💸Cash Payment No Advance Call Girls Surat 🧿 9332606886 🧿 High Class Call Girl...India Call Girls
 
Call Girls In Indore 📞9235973566📞Just Call Inaaya📲 Call Girls Service In Indo...
Call Girls In Indore 📞9235973566📞Just Call Inaaya📲 Call Girls Service In Indo...Call Girls In Indore 📞9235973566📞Just Call Inaaya📲 Call Girls Service In Indo...
Call Girls In Indore 📞9235973566📞Just Call Inaaya📲 Call Girls Service In Indo...Sheetaleventcompany
 
💸Cash Payment No Advance Call Girls Hyderabad 🧿 9332606886 🧿 High Class Call ...
💸Cash Payment No Advance Call Girls Hyderabad 🧿 9332606886 🧿 High Class Call ...💸Cash Payment No Advance Call Girls Hyderabad 🧿 9332606886 🧿 High Class Call ...
💸Cash Payment No Advance Call Girls Hyderabad 🧿 9332606886 🧿 High Class Call ...India Call Girls
 

Dernier (20)

The Events of Cardiac Cycle - Wigger's Diagram
The Events of Cardiac Cycle - Wigger's DiagramThe Events of Cardiac Cycle - Wigger's Diagram
The Events of Cardiac Cycle - Wigger's Diagram
 
Call Now ☎ 8868886958 || Call Girls in Chandigarh Escort Service Chandigarh
Call Now ☎ 8868886958 || Call Girls in Chandigarh Escort Service ChandigarhCall Now ☎ 8868886958 || Call Girls in Chandigarh Escort Service Chandigarh
Call Now ☎ 8868886958 || Call Girls in Chandigarh Escort Service Chandigarh
 
💚Chandigarh Call Girls Service 💯Jiya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Jiya 📲🔝8868886958🔝Call Girls In Chandigarh No...💚Chandigarh Call Girls Service 💯Jiya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Jiya 📲🔝8868886958🔝Call Girls In Chandigarh No...
 
Independent Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bang...
Independent Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bang...Independent Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bang...
Independent Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bang...
 
❤️Call Girl In Chandigarh☎️9814379184☎️ Call Girl service in Chandigarh☎️ Cha...
❤️Call Girl In Chandigarh☎️9814379184☎️ Call Girl service in Chandigarh☎️ Cha...❤️Call Girl In Chandigarh☎️9814379184☎️ Call Girl service in Chandigarh☎️ Cha...
❤️Call Girl In Chandigarh☎️9814379184☎️ Call Girl service in Chandigarh☎️ Cha...
 
Indore Call Girl Service 📞9235973566📞Just Call Inaaya📲 Call Girls In Indore N...
Indore Call Girl Service 📞9235973566📞Just Call Inaaya📲 Call Girls In Indore N...Indore Call Girl Service 📞9235973566📞Just Call Inaaya📲 Call Girls In Indore N...
Indore Call Girl Service 📞9235973566📞Just Call Inaaya📲 Call Girls In Indore N...
 
Low Rate Call Girls Pune {9142599079} ❤️VVIP NISHA Call Girls in Pune Maharas...
Low Rate Call Girls Pune {9142599079} ❤️VVIP NISHA Call Girls in Pune Maharas...Low Rate Call Girls Pune {9142599079} ❤️VVIP NISHA Call Girls in Pune Maharas...
Low Rate Call Girls Pune {9142599079} ❤️VVIP NISHA Call Girls in Pune Maharas...
 
2024 PCP #IMPerative Updates in Rheumatology
2024 PCP #IMPerative Updates in Rheumatology2024 PCP #IMPerative Updates in Rheumatology
2024 PCP #IMPerative Updates in Rheumatology
 
❤️Amritsar Call Girls Service☎️98151-129OO☎️ Call Girl service in Amritsar☎️ ...
❤️Amritsar Call Girls Service☎️98151-129OO☎️ Call Girl service in Amritsar☎️ ...❤️Amritsar Call Girls Service☎️98151-129OO☎️ Call Girl service in Amritsar☎️ ...
❤️Amritsar Call Girls Service☎️98151-129OO☎️ Call Girl service in Amritsar☎️ ...
 
Ulhasnagar Call girl escort *88638//40496* Call me monika call girls 24*
Ulhasnagar Call girl escort *88638//40496* Call me monika call girls 24*Ulhasnagar Call girl escort *88638//40496* Call me monika call girls 24*
Ulhasnagar Call girl escort *88638//40496* Call me monika call girls 24*
 
💸Cash Payment No Advance Call Girls Bhopal 🧿 9332606886 🧿 High Class Call Gir...
💸Cash Payment No Advance Call Girls Bhopal 🧿 9332606886 🧿 High Class Call Gir...💸Cash Payment No Advance Call Girls Bhopal 🧿 9332606886 🧿 High Class Call Gir...
💸Cash Payment No Advance Call Girls Bhopal 🧿 9332606886 🧿 High Class Call Gir...
 
Call Girls Service Amritsar Just Call 9352988975 Top Class Call Girl Service ...
Call Girls Service Amritsar Just Call 9352988975 Top Class Call Girl Service ...Call Girls Service Amritsar Just Call 9352988975 Top Class Call Girl Service ...
Call Girls Service Amritsar Just Call 9352988975 Top Class Call Girl Service ...
 
Premium Call Girls Bangalore {9179660964} ❤️VVIP POOJA Call Girls in Bangalor...
Premium Call Girls Bangalore {9179660964} ❤️VVIP POOJA Call Girls in Bangalor...Premium Call Girls Bangalore {9179660964} ❤️VVIP POOJA Call Girls in Bangalor...
Premium Call Girls Bangalore {9179660964} ❤️VVIP POOJA Call Girls in Bangalor...
 
Top 20 Famous Indian Female Pornstars Name List 2024
Top 20 Famous Indian Female Pornstars Name List 2024Top 20 Famous Indian Female Pornstars Name List 2024
Top 20 Famous Indian Female Pornstars Name List 2024
 
Call Girl Service In Mumbai ❤️🍑 9xx000xx09 👄🫦Independent Escort Service Mumba...
Call Girl Service In Mumbai ❤️🍑 9xx000xx09 👄🫦Independent Escort Service Mumba...Call Girl Service In Mumbai ❤️🍑 9xx000xx09 👄🫦Independent Escort Service Mumba...
Call Girl Service In Mumbai ❤️🍑 9xx000xx09 👄🫦Independent Escort Service Mumba...
 
❤️Zirakpur Escorts☎️7837612180☎️ Call Girl service in Zirakpur☎️ Zirakpur Cal...
❤️Zirakpur Escorts☎️7837612180☎️ Call Girl service in Zirakpur☎️ Zirakpur Cal...❤️Zirakpur Escorts☎️7837612180☎️ Call Girl service in Zirakpur☎️ Zirakpur Cal...
❤️Zirakpur Escorts☎️7837612180☎️ Call Girl service in Zirakpur☎️ Zirakpur Cal...
 
💞 Safe And Secure Call Girls Prayagraj 🧿 9332606886 🧿 High Class Call Girl Se...
💞 Safe And Secure Call Girls Prayagraj 🧿 9332606886 🧿 High Class Call Girl Se...💞 Safe And Secure Call Girls Prayagraj 🧿 9332606886 🧿 High Class Call Girl Se...
💞 Safe And Secure Call Girls Prayagraj 🧿 9332606886 🧿 High Class Call Girl Se...
 
💸Cash Payment No Advance Call Girls Surat 🧿 9332606886 🧿 High Class Call Girl...
💸Cash Payment No Advance Call Girls Surat 🧿 9332606886 🧿 High Class Call Girl...💸Cash Payment No Advance Call Girls Surat 🧿 9332606886 🧿 High Class Call Girl...
💸Cash Payment No Advance Call Girls Surat 🧿 9332606886 🧿 High Class Call Girl...
 
Call Girls In Indore 📞9235973566📞Just Call Inaaya📲 Call Girls Service In Indo...
Call Girls In Indore 📞9235973566📞Just Call Inaaya📲 Call Girls Service In Indo...Call Girls In Indore 📞9235973566📞Just Call Inaaya📲 Call Girls Service In Indo...
Call Girls In Indore 📞9235973566📞Just Call Inaaya📲 Call Girls Service In Indo...
 
💸Cash Payment No Advance Call Girls Hyderabad 🧿 9332606886 🧿 High Class Call ...
💸Cash Payment No Advance Call Girls Hyderabad 🧿 9332606886 🧿 High Class Call ...💸Cash Payment No Advance Call Girls Hyderabad 🧿 9332606886 🧿 High Class Call ...
💸Cash Payment No Advance Call Girls Hyderabad 🧿 9332606886 🧿 High Class Call ...
 

poison and drug info.pdf

  • 1. BASIC CONCEPT OF MEDICINE & POISON INFORMATION SERVICES Submitted By, Ameena Kadar K A First Sem M Pharm Clinical Pharmacy Practice Sanjo College of Pharmaceutical Studies Submitted To, Soumya Ma’am Assistant Professor Dept. of Pharmacy Practice
  • 2. 1 DRUG INFORMATION SERVICES INTRODUCTION  Providing drug information is a fundamental responsibility of all pharmacists.  Drug information means providing clinically relevant information on any aspect of drug use relating to individual patients, or general information on how best to use drugs for populations.  Pharmacists have a unique range of knowledge and skills which are required for drug information practice. These include knowledge of pharmaceutics, pharmacology, pharmacokinetics and pharmacotherapy. All of these are required to optimize the use of drugs in the treatment and prevention of disease.  Drug information can be challenging but also exciting. It requires much of the knowledge that pharmacists acquire as students and allows them to apply these skills to improve health outcomes.  Providing a drug information service is a professional activity which carries the same responsibilities as direct patient care. Information provided to support policy decisions can affect many people (hospital, regional or national populations) and poor-quality information can cause as much damage to public health as inadequate quality control in pharmaceutical manufacturing.  The term ‘Drug Information Service’ can be applied to any activity where information about drug use is transferred, and includes patient-related aspects of pharmaceutical care.  A ‘Drug Information Centre’ is an area where pharmacists (or other health professionals) specialize in providing information to health professionals or the public.
  • 3. 2  The term ‘medicines information’ can be used to avoid confusion with services which are limited to problems relating to drugs of abuse.  Drug information centres were first established in the USA in the early 1960s and developed in parallel with clinical pharmacy services. Drug information centres can limit their services to health professionals but some also offer a service to the public, there are also centres which specialize in information for the public. DRUG INFORMATION RESOURCES Information sources have traditionally been categorized as primary, secondary or tertiary, according to the nature of the content and speed of publication. However, the most important point is to distinguish primary sources (original reports) from all other sources (reviews). Electronic formats, and ready access to updates, have blurred the divisions previously applied to secondary and tertiary sources. PRIMARY RESOURCES  Primary literature describes unique experiences which change the world in terms of available knowledge.  Primary reports include the results of research at all levels (from molecular science to controlled clinical trials) and also clinical experience in the form of individual responses to drugs and small case series.  Primary literature is published principally in scientific journals in the form of research results, concise reports and letters to the editor.  Adverse drug reaction reports are an example of primary literature and these can be published in journals or contributed to pharmacovigilance centres.
  • 4. 3  Primary literature can be seen as the building block on which medical science (and therefore clinical practice) is based.  It is essential to understand its nature and to be able to critically analyze its content using the full text of reports.  Primary literature provides a ‘first look’ at how clinical practice may evolve but it must be constantly monitored and interpreted carefully. Eg: Journal of Clinical and Hospital Pharmacy, Journal of Pharmaceutical Sciences. SECONDARY RESOURCES  It consists of reviews of primary reports.  Journals often publish a mixture of primary and secondary reports but there are also journals which are devoted to reviews of previously published material.  Reviews can be informal, often by a single author recognized as a specialist in the field.  These provide a personal perspective of the literature and can include comments on how the author might apply the information in practice.  This type of report is sometimes called a ‘narrative review’ and this term may appear in the title to distinguish it from a more formal analysis, referred to as a ‘systematic review’  In a systematic review, the authors (usually a team) use a rigorous (and defined) method to search for all relevant information (including unpublished studies) and select those studies which meet criteria for scientific quality.  The selected studies are then analyzed and conclusions drawn.  In many cases, the results of a number of studies are merged using a process called ‘meta-analysis’, this process aims to create the equivalent of one large study with greater statistical power than the separate studies.
  • 5. 4  Secondary sources provide a condensed and refined view of primary data and are often used in drug information practice to provide rapid responses to clinical questions.  However, published reviews may not include recent primary reports, and narrative reviews may reflect the authors’ clinical perspective and limited access to the relevant information.  Eg: Index Medicus, MEDLINE, PubMed, Ovid, SEDBASE, Toxline, Cochrane Database. TERTIARY RESOURCES  Tertiary resources are summaries of the primary and secondary published literature.  Printed textbooks are the main example and these are characterized by a slow rate of revision compared to secondary sources.  Although they are revised less frequently, these texts tend to be more comprehensive and should undergo a more thorough review and editing process than secondary sources.  Many major textbooks are now published electronically as well as in print, so sections can be updated progressively rather than waiting for a complete revision at the time of printing (usually every 3–5 years).  In drug information practice, a tertiary text will usually be consulted first as a quick reference and, if necessary, secondary and primary sources are then checked for a more complete response.  Eg; Harrisons Principles of Internal Medicine, Martindale, Pharmacopoeias, Merck index, Merck manual etc.
  • 6. 5 OTHER SOURCES OF DRUG INFORMATION The internet has enhanced our access to information from reputable organizations. National libraries offer reliable information and links to useful sites, including openaccess journals. Many clinical guidelines and drug assessments are not indexed in bibliographical databases but can be located on recognised sites or using search engines which focus on reputable sources of information. Examples of specific sites include:  National Institute for Health and Clinical Excellence, UK (www.nice.org.uk)  National Prescribing Centre, UK (www.npc.co.uk)  National Prescribing Service, Australia (www.nps.org.au)  Canadian Agency for Drugs and Technologies in Health (www.cadth.ca) Search tools for clinical guidelines include:  National Guideline Clearinghouse, USA (www.guidelines.gov)  National Library for Health, UK (www.library.nhs.uk). Product information is available for approved drugs in many countries including:  DailyMed, USA (dailymed.nlm.nih. gov/dailymed)  European Medicines Agency (www.emea.europa.eu)  Medicines.org.uk, UK (www.medicines.org.uk). Drug information about understands all available information resources, selecting and using the most useful, and being able to retrieve and interpret that information in a clinical or public health context.
  • 7. 6 FUNCTIONS OF DIC 1. Promoting rational drug evaluation and therapeutics o It can evaluate the information on products available in the market and prepare rationalised drug monographs that may overcome the imbalance between commercially oriented and purely scientific sources of drug information. o Drug product oriented stored at also includes data on product availability, manufacturer, package strength, cost, OTC products, and identification of foreign drug products. 2. Patient specific consultations o Drug information specialist may actively disseminate information related to patient care where he attends ward rounds or reviews a patient’s chart along with physicians. o Specialist may passively participate in patients care by responding to queries received at the DIC. 3. Adverse reaction reporting: o The drug information specialist plays an important role by following up such patients filling and analysing the forms needed for detection and reporting adverse reactions. 4. Drug interaction monitoring: o Multiple drug therapies have resulted in growing incidence of drug-drug interaction. The DIC services may evaluate reports on drug interactions and suggest ways to detect interactions and to determine their clinical significance. 5. Drug interaction with diagnostic tests: o Many diagnostic and pathological test results are found to be modified due to concurrent drug administration. DIC service can provide manual or
  • 8. 7 computerised information on such interferences and saves the patients of under surgical procedures and wrong diagnosis based on altered test result. 6. Drug utilisation review o The pharmacist at the drug information centres can be actively involved in conducting drug utilisation reviews to determine patterns of drug usage in the hospital. 7. Pharmacy and therapeutics committee related function o This is the most important non patients’ specific activity of the DIC to provide specific drug reports for evaluations by the committee. 8. Investigational drug information o The drug information specialist can participate in clinical investigations to establish safety and efficacy of new drug. He can assist in preparation of protocols, applications & literature reports & investigational drugs. 9. Publication of news letters o DIC can publish newsletters, news bulletins or periodic reports; subject matter in such publications includes all the topics of current interest to staff. o E g : news products , drug reviews , new drug policies , specific diseases , comparative therapies. 10. Teaching and education activities o Educational functions include developing continuing education programmes for staff pharmacist, a resident doctor, intern nurses etc… DIC can organise seminars, conference, workshops and guest lectures by eminent scientist. 11. Consumer awareness programmes & community pharmacy based activity o The DIC can create awareness for safe drug usage. o It can prepare attractive sheets for consumers for audio-visual aids such as cassette tapes called media messages for counselling of ambulatory patients. 12. Literature retrieval services o Drug literature is defined as any published paper on preparations with the potential therapeutic or diagnostic activity. o A DIC can be at the interference of this literatures and the user who seeks it. o Having up to date information alone does not automatically ensure information of high quality but the effective communication of this information to the person who requested for it is also important.
  • 9. 8  APPROACH TO ANSWERING DRUG INFORMATION QUERIES The major steps involved are: Step 1: Secure demographics of requester Step 2: Obtain background information Step 3: Determine and categorise the ultimate questions Step 4: Develop search strategy and conduct search Step 5: Perform evaluation, analysis and synthesis Step 6: Formulate and provide response Step 7: Conduct follow up & documentation. Step 1: Secure demographics of requester o The requesters name, position, training and anticipated knowledge are important to determine the approval and final response to the question. Step 2: Obtain background information o The ability to obtain background information is essential for effectively using the modified systematic approach. o The background question should be specific for the nature of the request. o When a question involves a patient, the patient’s age, weight and sex are usually needed. On addition, the patients’ diagnosis, other comorbidities, and hepatic & renal function are often important to assess. o It is also advisable to find out if the requester has checked any resources previously so as to avoid duplication of work. Step 3: Determine & categorise the ultimate question o The ultimate question may differ significantly from the if the requester posed a general question.
  • 10. 9 o Adequate background information is needed to determine the ultimate question. Thereafter the question should be categorised, as it will help in developing search strategy. Step 4: Develop search strategy and conduct search o The information resources are selected based on the probability of containing the desired information on data. o If query is about any drug interactions, standard reference on drug interactions is first line resources. However, if one of the drugs was a recently introduced drug a Medline search would be more appropriate. Step 5: Perform evaluation, analysis and synthesis o The information retrieved must be reviewed for the response to be analysed and synthesised with the consideration of the background information obtained previously. o Analysis and synthesis together assist in forming opinions, arriving at judgements and ultimately drawing conclusions. Step 6: Formulate & provide response o This involves a series of steps that must be performed completely objectively and in a logical sequence. o The way in which answers are communicated plays a major role in determining how drug information accepted by physicians. o Conflicting viewpoints or considerations should be clear stated. Specific recommendation must be scientifically sound & clearly justified.
  • 11. 10 o In the hospital setting the majority of questions will be answered verbally and responses should be brief, concise and accurate and provided in a timely manner. Step 7: Conduct follow up & documentation o Follow up is the process of verifying the appropriateness, correctness, and completeness of a response after it has been given. o When recommendations are made, follow up should always be done in a timely manner. This follows pharmacist to know if the recommendations were accepted and implemented. o In a hospital setting this may involve visiting the ward and offering additional advice & information. o Documentation of DI query is essential for purpose of quality assurance, budget allocation, promotion of the DI service & to minimise liability. PREPARATION OF WRITTEN AND VERBAL RESPONSES: Preparation of written response: Goal: Is to prepare a document that is clear, concise, complete and correct. General rules:  Organize the information before starting to write (what and how to write)  Use proper spelling and grammar  Preferably avoid passive voice throughout
  • 12. 11  Avoid writing in the first person and second person wherever possible.  Prepare a document in a presentable manner (neat)  Keep things as simple and direct as possible  Consider whether tables or graphs or figure would make the document simpler  Avoid using abbreviations or acronyms (or quote at first instance in parentheses)  If the document is long , use sub headings  Present it in correct order as required  Write in your own words  At first make sure that all of the information is down on paper. Once that occurs go back, revise, and perhaps reorganize the document. Specific document sections: It should contain  Introduction  Body  Conclusion Introduction: Should inform what the remainder of the document is to cover Body: Should contain all the details of the document.  Do not include unnecessary information (even if it is interesting)
  • 13. 12  Do not stray from the subject  Subdivide the document further in a logical order and as appropriate when necessary.  Always focus end point Conclusion:  Should be placed at the end of the document  Avoid extrapolating beyond the information available  Readers need something to bring their thoughts together at the end Preparation of verbal response:  Verbal communications are most frequently used in practice setting  Need to use good verbal communication skills  Deliver the information at an ideal place  Deliver the content confidently  Make analogous to the delivery to the delivery of a presentation or lecture  Use appropriate language with good grammar  Use correct pronunciation all of terms of the document  Listen carefully when clarification is sought  Clarify all doubts confidently  Must be prepared for additional questions  Show evidence where necessary or appropriate.
  • 14. 13
  • 15. 14
  • 16. 15 POISON INFORMATION SERVICES The number of chemicals, poisonous household products and medicines on the Indian market is increasing day by day, which consequently increases the risk of misuse of these products and leads to greater incidence of intentional and unintentional poisoning. The impact of poison information services on the quality of healthcare is very significant, and hence there is an increased need for poison information services to prevent and manage the morbidity and mortality caused by poisoning. Such services are designed to provide immediate, round-the-clock toxicity assessment and treatment recommendations for the effective management of poisoning cases. Poison information (PI) is a specialized area of drug information which includes information about the toxic effects of chemicals and pesticides, hazardous material spills, household products, overdose of therapeutic medicines, plants including mushrooms, animal toxins from the bites of snakes, spiders and other venomous creatures, and stings. A poison information service deals with the risk assessment, diagnosis, management and prevention of exposure to any poison, in patients of any age irrespective of type (intentional or accidental) and route of exposure. The goal of poison information services is to reduce the morbidity and mortality caused by poisoning and improves the patients’ health-related quality of life. These services are mainly provided to the general public as well as to healthcare professionals. Specialist pharmacists with knowledge of clinical toxicology and with the skills required for provision of drug and poison information can contribute
  • 17. 16 to the management of poisoning cases. Pharmacists can acquire the required knowledge and skills through appropriate training in the area of poison information which enables them to evaluate poisoning cases with in-depth understanding, and thereby provide valuable information.  Poison information services are provided by a specialized center known as a poison information center (PIC) or poison control center (PCC).  It provides immediate information on poisoning management through well trained poison information specialists.  A PIC functions 24 hours a day, round the year with the objective of continually improving health outcomes by providing a timely, safe information service appropriate to the needs of the enquirer related to poisoning, suspected poisoning and prevention of poisoning.  It also aims to prevent unnecessary visits to doctors and hospitals and to ensure that patients who are poisoned receive the most effective treatment promptly.  The size of the PIC may vary depending on call volumes and should ideally be located adjacent to the emergency department.  A PIC may operate locally, providing services to populations of a specific geographical location, or may extend its service to the regional/national level. Role of the Poison Information Centre  To minimize poisoning deaths due to accidental or intentional poisoning or overdose among the general public.  Providing the general public and healthcare professionals with information on poisoning prevention and management (identification/ assessment and management) by providing rapid access to poisoning information.
  • 18. 17  Educational programs for healthcare professionals of the hospital where the PIC is located, and outreach programs at smaller hospitals may also be developed.  The identification of the poisoning substance, first aid measures and the treatment and prevention of poisoning cases.  PIC staff can also assist with rationalization of antidote stocks.  Healthcare professionals have access to up-to-date and relevant information about poisoning management. Functions of a poison information center  Patient management  Toxicological analytical services  Toxic vigilance  Education and training of healthcare professionals and public  Prevention of poisoning  Research in poisoning  Development of therapeutic guidelines/protocols for poison management. Organization The organization pattern of a PIC should be based on the anticipated ‘ideal human exposure call volume’ (average number of queries that the poison information center receives regarding the management of poisoning cases in humans). The majority of PICs are connected with hospitals and to some extent to universities and with the public health service of the country at national or regional level. Networking with all other existing PICs at a regional, state or national level in a systematic way is essential not only for maintaining uniformity of services but also to ensure better utilization of available resources. This also allows the development
  • 19. 18 of a national database on poisoning and the formulation of expert management advice. Personnel An adequate number of staff is essential for effective and round the-clock functioning of the Centre. The PIC is usually staffed by a physician (medical director), a pharmacist (technical director), an administrator, at least one clinical toxicologist and a poison information specialist with the required secretarial assistance. Personnel working in PICs should have unique qualifications and distinct responsibilities. The responsibility of medical and technical directors is to promote research, raise funds, ensure quality service and undertake further development of the information service. The poison information specialists should be trained properly to carry out the basic functions of the Centre. The responsibilities of the poison information specialist include:  Provide poison information  Prepare standard protocols  Maintain an accurate record of all queries  Participate in continuing education  Update and maintain information resources  Carry out research activities. Facilities Location: A feasible location for the PIC is within a hospital or an area closely associated with a hospital providing emergency and intensive care services.
  • 20. 19 Ideally, the PIC should be co-located with a hospital clinical toxicology service which is concerned with the identification, treatment and prevention of the harmful effects of chemicals, including natural substances, on humans. This type of setup will provide ready access to a network of medical disciplines that will support and enhance the work of the Centre. Other locations include a medical library, medical university, pharmacy department and medical or pharmacy college. Regardless of the location, it is wise to have a liaison with a hospital/ university medical library. Space: The PIC should be placed in a spacious facility to accommodate the service’s staff and needs. A work area of 200 square feet per workstation is recommended, with a separate office for the medical director and manager/ supervisor. The working area should have adequate lighting and ventilation. Equipment: The PIC should be well equipped with the necessary basic facilities, including furniture, to allow it to function effectively. Communication equipment is vital for the Centre. As most communication with the enquirer is over the phone, at least two telephones with sufficient incoming lines with toll-free numbers should be reserved to receive the queries. It is essential to have other fast and reliable communication options such as fax and e-mail. It is also important to be equipped adequately with computers, printers, a photocopying machine and uninterrupted power supply (UPS). Book shelves and filing cabinets for storage of case records and documentation files for systematic storage and easy retrieval of data are also essential. A lockable cabinet should also be available to store confidential data. For toxicological screening purposes, either the required facilities need to be created or the center can liaise with a well-equipped laboratory which carries out toxicological analysis.
  • 21. 20 Information resources: Information pertaining to the management of poisoning cases is available from a wide range of information sources including primary, secondary and tertiary resources and the internet Tertiary Resources:  Medical and general toxicology: Murray L, Dary F, Little M and Cadogan M (eds). 2007. Toxicology Handbook. Churchill Livingstone, Elsevier: Australia.  Goldfrank LR, Flomenjbaum NE and Lewin NA (eds).2006. Goldfrank’s Toxicologic Emergencies, 6th ed. Appleton and Lange: Norwalk. Secondary resources:  POISINDEX  WikiTox / http://curriculum.toxicology.wikispaces.net/  Toxbase  MEDLINE  Toxicology abstracts  Toxline  Excerpta medica  Index medicus. Primary resources  Human and experimental toxicology. Published by Macmillan, Basingstoke, England.  On-line journal scanning services, for example, AMEDEO, Current Awareness in Clinical Toxicology  Clinical toxicology. Published by Informa Healthcare.  Neurotoxicology. Published by Raven Press, New York, USA
  • 22. 21 Legal and ethical prerequisites: It is recommended that the PIC be officially reIntoxcognised either by government authorities or the WHO. To carry out the functions effectively, the Centre should have independent status, stability and neutrality. The Centre should maintain confidentiality of the data it handles. Usually the Centre is required to provide the information free of cost to enquirers. But, occasionally, the Centre may charge for the services being offered for its own viability. In such instances, it should be on a ‘no loss–no profit’ basis. Policies and procedures: For the effective functioning of the Centre, it should have well-defined policies and procedures. The policies and procedures may vary from one Centre to another depending on the scope of service, financial support and the Centre’s requirements. The PIC should develop policies for personnel, methods of operation, documentation of services and quality assurance programs, staff training, confidentiality, and ethical and legal aspects. Policies pertaining to personnel should indicate the mode of recruitment of personnel, qualifications and training required if any, and the position of staff with distinct responsibilities. The method of operation should detail the handling of poisoning cases starting from receipt of the query until final documentation. Training of staff: Adequate training to site personnel is essential especially for newly recruited and inexperienced staff. The PIC should provide either internal or external training to the staff in the various areas of poison information. The PIC should develop and implement a needs-based staff training manual. This would assist in training new and inexperienced staff in various areas and ensure that uniformity in training is maintained. Training components may include updating of knowledge in clinical toxicology, communication skills, handling of databases, retrieval of information, interpretation and analytical skills, and handling of equipment such as computers, telephones and other instruments.
  • 23. 22 Systematic Approach in Handling Poison Information Queries Step 1: Obtain the Requester’s Demographics Receive and accept the query related to the service either over the phone or in person. Establish the identity of the enquirer by gathering contact details. Also obtain all required information from the requester that will allow you to reply to the query. If the enquirer is a healthcare professional, the position and anticipated knowledge of the enquirer should be determined. If it takes time to obtain information, ask the enquirer to call back or note their contact number. Queries relating to potentially serious poisoning cases need to be answered immediately, and for a query with minimal toxicity an appropriate deadline for a response should be established. Step 2: Collect Background Information It is important to collect all the required background information to provide appropriate information. Obtaining relevant information often requires targeted questioning, and additional care is required to accurately identify the poisoning substance. However, all critical information should be obtained in a short time to maximize the patient outcome as otherwise it may be counter-productive. Step 3: Assess the Patient’s Condition Appropriate background information about the patient’s condition allows for better understanding of the actual query to be answered. Firstly, the urgency of the situation should be assessed in terms of whether it is an emergency, serious, not serious or no problem. Assess the likelihood of toxicity associated with the exposed toxins based on the nature of the substance, type of exposure and quantity consumed. Assessment of signs and symptoms of toxicity and analytical testing of
  • 24. 23 the compound may greatly aid in determining appropriate patient management and whether first aid, observation, medical treatment, home treatment or no treatment is appropriate. Step 4: Develop and Conduct a Search Strategy Select and prioritizes the information resources based on the probability of locating the desired information. It is ideal to locate the information based on the probable efficiency of information sources in the literature hierarchy. Although in many instances the information can be provided with the use of tertiary resources, it is worthwhile to consider other information sources, as appropriate. Step 5: Evaluate and Provide Information The retrieved information should be thoroughly and critically evaluated. Comprehensive information needs to be provided to ensure the recommended line of management is based on all of the current evidence available. The response should be generated only after critically evaluating all the information available. However, consistency of information among the resources used should be ensured. Interpretation of the information available in various resources should be patient specific and made considering all relevant factors. In case of lack of information or conflict of information in the available sources, a decision may be taken based on professional knowledge and previous experience. Information may be provided verbally/written/printed form/through fax or e mail, as appropriate. However, timely or immediate delivery of the response is critical. If more time is required to evaluate and formulate the response, minimum vital information is to be provided at the earliest possible time.
  • 25. 24 Step 6: Conduct Follow-up and Document Follow-up of the case is vital to assess the patient outcome and also to ascertain whether provision of any additional information is useful in the management of the poisoning. A personal visit may be more useful and is possible only when the victim is admitted to a hospital where the poison information Centre is co-located. In other cases, follow- up can be made through other modes including telephone enquiry and e-mail. Documenting the details of enquirer, query and response. Step 7: Maintain Confidentiality All issues relating to the query are to be kept confidential by the Centre for socio- legal reasons. The details of the enquirer should not be disclosed to anyone, including family members and healthcare professionals, without the consent of the enquirer. COMPARISON OF PIC AND DRUG INFORMATION CENTRE
  • 26. 25 Conclusion Skilled pharmacists can play an important role as poison information specialists. This role is most effective when the PIC is co- located with a clinical toxicology service within a hospital treating poisoning cases. Experienced pharmacists may also serve as advisors to analytical toxicology laboratories, as expert witnesses in legal proceedings, and may also work in the safety offices of the pharmaceutical industry. There is a need for a centralized database and expert advice on toxicological cases to assist physicians, and to educate the public in the prevention and the overall management of poisoning in India. REFERENCES: A Textbook of Clinical Pharmacy Practice: Essential Concepts and Skills. By G Parthasarathi, Karin Nyfort-Hansen, Milap C Nahata. 2nd Edition, Page No. 534-584. THANK YOU!